ArticleJournal of cellular and molecular medicine2026
RETRACTION: EZH2 Promotes Invasion and Tumour Glycolysis by Regulating STAT3 and FoxO1 Signalling in Human OSCC Cells.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionM. Zheng, M.-X. Cao, X.-J. Luo, L. Li, K. Wang, S.-S. Wang, H.-F. Wang, Y.-J. Tang, Y.-L. Tang, X.-H. Liang, "EZH2 Promotes Invasion and Tumour Glycolysis by Regulating STAT3 and FoxO1 Signalling in Human OSCC Cells," Journal of Cellular and Molecular Medicine 23, no. 10 (2019): 6942-6954, https://doi.org/10.1111/jcmm.14579. The above article, published online on 31 July 2019 in Wiley Online Library (wileyonlinelibrary.com) has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, instances of image duplication have been identified between Figures 2C and 3C, between Figures 2A and 3A, and between Figures 2D and 5A. Furthermore, image elements in Figures 2C and 3C have been published previously by the same author group in a different scientific context. The clarification provided by the authors was insufficient to adequately address the concerns raised, as additional inaccuracies were identified by the authors during their review of the original data. Accordingly, the article has been retracted, as the editors no longer have confidence in the overall reliability of the data or in the conclusions presented in the article. The authors have been informed of the retraction decision but were not available for final confirmation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.